IMPL Annual EBIT
-$83.18 M
-$11.70 M-16.36%
31 December 2022
Summary:
As of February 5, 2025, IMPL annual earnings before interest & taxes is -$83.18 million, with the most recent change of -$11.70 million (-16.36%) on December 31, 2022. During the last 3 years, it has fallen by -$41.62 million (-100.13%).IMPL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMPL Quarterly EBIT
-$12.81 M
+$3.29 M+20.45%
01 September 2023
Summary:
As of February 5, 2025, IMPL quarterly earnings before interest & taxes is -$12.81 million, with the most recent change of +$3.29 million (+20.45%) on September 1, 2023. Over the past year, it has increased by +$8.43 million (+39.68%).IMPL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMPL TTM EBIT
-$70.11 M
+$8.43 M+10.73%
01 September 2023
Summary:
As of February 5, 2025, IMPL TTM earnings before interest & taxes is -$70.11 million, with the most recent change of +$8.43 million (+10.73%) on September 1, 2023. Over the past year, it has increased by +$19.09 million (+21.40%).IMPL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMPL EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.4% | +39.7% | +21.4% |
| 3 y3 years | -100.1% | -42.4% | -120.7% |
| 5 y5 years | -100.1% | -30.6% | -615.0% |
IMPL EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +103.7% | +42.4% | +615.0% |
Impel Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$12.81 M(-20.4%) | -$70.11 M(-10.7%) |
| June 2023 | - | -$16.10 M(-29.8%) | -$78.54 M(-5.8%) |
| Mar 2023 | - | -$22.95 M(+25.8%) | -$83.42 M(+0.3%) |
| Dec 2022 | -$83.18 M(+16.4%) | -$18.24 M(-14.1%) | -$83.19 M(-6.7%) |
| Sept 2022 | - | -$21.24 M(+1.2%) | -$89.20 M(-1.3%) |
| June 2022 | - | -$20.98 M(-7.7%) | -$90.38 M(+7.2%) |
| Mar 2022 | - | -$22.72 M(-6.3%) | -$84.34 M(+18.0%) |
| Dec 2021 | -$71.49 M | -$24.25 M(+8.1%) | -$71.49 M(+17.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$22.43 M(+50.1%) | -$60.80 M(+28.3%) |
| June 2021 | - | -$14.94 M(+51.4%) | -$47.38 M(+4.4%) |
| Mar 2021 | - | -$9.87 M(-27.3%) | -$45.40 M(+0.1%) |
| Dec 2020 | -$45.33 M(+9.1%) | -$13.57 M(+50.8%) | -$45.33 M(+42.7%) |
| Sept 2020 | - | -$9.00 M(-30.6%) | -$31.76 M(+39.5%) |
| June 2020 | - | -$12.96 M(+32.2%) | -$22.77 M(+132.2%) |
| Mar 2020 | - | -$9.81 M | -$9.81 M |
| Dec 2019 | -$41.57 M | - | - |
FAQ
- What is Impel Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals annual EBIT year-on-year change?
- What is Impel Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals quarterly EBIT year-on-year change?
- What is Impel Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals TTM EBIT year-on-year change?
What is Impel Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of IMPL is -$83.18 M
What is the all time high annual EBIT for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high annual earnings before interest & taxes is -$40.84 M
What is Impel Pharmaceuticals annual EBIT year-on-year change?
Over the past year, IMPL annual earnings before interest & taxes has changed by -$11.70 M (-16.36%)
What is Impel Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of IMPL is -$12.81 M
What is the all time high quarterly EBIT for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$9.00 M
What is Impel Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, IMPL quarterly earnings before interest & taxes has changed by +$8.43 M (+39.68%)
What is Impel Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of IMPL is -$70.11 M
What is the all time high TTM EBIT for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high TTM earnings before interest & taxes is -$9.81 M
What is Impel Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, IMPL TTM earnings before interest & taxes has changed by +$19.09 M (+21.40%)